Premier, Inc. (PINC) Q1 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates mixed signals: financial performance declined YoY, but there was a notable gain from a lawsuit settlement. The company announced a significant share repurchase and dividend payout, which are positive. However, management's vague responses on certain issues during the Q&A, coupled with an 8% revenue decline, suggest uncertainty. The market cap indicates a moderate reaction, resulting in a neutral stock price prediction.
Key Financial Performance
Total Net Revenue $248.1 million, decreased 8% year-over-year due to lower net administrative fees revenue driven by an expected increase in the aggregate blended member fee share.
GAAP Net Income $72.9 million, benefited from a $57 million non-operating gain from the derivative lawsuit settlement.
Total Adjusted EBITDA $62.4 million, declined year-over-year due to decreased net administrative fees revenue and additional investments in the Supply Chain Co-Management business.
Adjusted Net Income Decreased year-over-year primarily due to the same factors impacting adjusted EBITDA, partially offset by a decrease in the effective income tax rate.
Adjusted Earnings Per Share Decreased year-over-year due to the same factors affecting adjusted net income, as well as completion of the $400 million accelerated share repurchase transaction.
Cash Flow from Continuing Operations $80 million, increased year-over-year primarily due to cash received from the derivative lawsuit settlement, partially offset by higher performance-related compensation payments.
Free Cash Flow $16.2 million, increased year-over-year primarily due to the same factors impacting cash flow from operations, along with a decrease in purchases of property and equipment.
Cash and Cash Equivalents $87 million as of September 30, 2024, decreased from $125.1 million as of June 30, 2024, primarily due to cash used for share repurchases.
Quarterly Cash Dividend $21.3 million, reflecting the company's commitment to returning capital to stockholders.
Share Repurchase Nearly $23 million of Class A common shares repurchased under the $1 billion share repurchase authorization.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Technology-Driven Supply Chain Strategy: Premier is focusing on leveraging technology and services to identify cost savings opportunities for members, enhancing contract penetration in group purchasing programs.
AI-Enabled Technology: Premier is utilizing AI-enabled technology to deliver insights and efficiencies for members, including a renewed engagement with a government agency to improve maternal and infant health outcomes.
Sustainability Efforts: Premier published its 2024 Sustainability Report and Climate Resilience Plan, highlighting initiatives aimed at improving healthcare and positively impacting communities.
Market Positioning: Premier's strategies are designed to be less reliant on political influences and more focused on addressing core challenges faced by members.
Partnerships: Continued partnerships with members, manufacturers, and government agencies to mitigate supply chain impacts from recent hurricanes.
Operational Efficiency: Premier is focusing on improving healthcare delivery by reducing costs and improving outcomes through technology.
Supply Chain Co-Management Growth: Growth in Supply Chain Services revenue driven by new agreements in the Supply Chain Co-Management business.
Leadership Transition: Craig McKasson is retiring, and Glenn Coleman will be introduced as the new Chief Administrative and Financial Officer.
Divestiture Strategy: Ongoing divestiture of Contigo Health business, with contributions included in current results but excluded from future guidance.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Competitive Pressures: The company faces competitive dynamics between Group Purchasing Organizations (GPOs) and distributors, with distributors increasingly leaning into prime vendor relationships and branded product sales, which may intensify competition.
Regulatory Issues: The company aims to be less reliant on political and regulatory influences, focusing instead on core challenges faced by members and customers.
Supply Chain Challenges: Recent hurricanes have impacted supply chains and hospital operations, necessitating Premier's support for member hospitals and health systems. Additionally, there are ongoing issues with IV solution shortages due to production challenges.
Economic Factors: Health systems are experiencing high labor costs, which are affecting profitability despite revenue growth. This creates pressure on health systems to seek efficiency improvements.
Contract Renewal Risks: The company anticipates a sequential decline in net administrative fees revenue in the second quarter due to ongoing contract renewal processes, which may affect overall revenue performance.
Performance Services Revenue: Performance Services revenue has faced challenges, including lower demand in consulting and timing of engagements, which could impact future profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Supply Chain Services Revenue: Revenue exceeded expectations, driven by strong member purchasing and contract renewals.
Performance Services Revenue: Revenue fell slightly short of expectations, primarily due to lower demand in the Consulting business.
Technology-Driven Supply Chain Strategy: Continued focus on leveraging technology to identify cost savings and enhance contract penetration.
Sustainability Efforts: Published 2024 Sustainability Report and Climate Resilience Plan, highlighting initiatives to improve healthcare and positively impact communities.
Partnerships: Renewed engagement with a government agency to improve maternal and infant health outcomes, and extended partnership with a pharma company for Alzheimer's research.
Fiscal 2025 Guidance: Reaffirmed guidance for fiscal 2025 based on first quarter performance and outlook for the remainder of the year.
Net Administrative Fees Revenue: Expected sequential decline in Q2 due to ongoing contract renewal process, with comparable performance anticipated in the second half.
Adjusted EBITDA and Earnings Per Share: Expected to be more back half weighted due to revenue cadence in Performance Services business.
Free Cash Flow: Expected to remain low in Q1, with a focus on disciplined capital deployment and return of capital to stockholders.
Share Repurchase Program: Continued execution of $1 billion share repurchase authorization, with $200 million planned for the current fiscal year.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Cash Dividend: Premier returned capital to stockholders through a quarterly cash dividend totaling $21.3 million in the first quarter of fiscal 2025.
Declared Dividend: The Board declared a dividend of $0.21 per share payable in December.
Share Repurchase Authorization: Premier has a $1 billion share repurchase authorization.
Share Repurchase Completed: As of September 30, 2024, Premier repurchased and retired nearly $23 million of Class A common shares under the $1 billion share repurchase authorization.
Additional Share Repurchase: In August, the Board approved an additional $200 million share repurchase under the existing authorization.
Open Market Repurchase: In August and September, Premier repurchased an additional $58 million of shares in the open market.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you give us an update on what you've been doing to help offset the shortages and where we stand today as they're trying to get that up and running?
A:We’ve been working with the Health Systems and the Federal Government to mitigate the overall issue, including coordinating with the FDA and HHS to fast track additional IV solutions. We're also looking at ways to conserve IV solutions and working with other suppliers to find additional sources.
Q:Can you discuss how the GPO contract renewals have been potentially joined to cross-sell other services?
A:As we go through contract renewals, we see significant opportunities to cross-sell our technology and advisory services, as healthcare systems are looking for total value to help bend the cost of supplies.
Q:What are your expectations regarding the sustainability of core utilization and the impacts of proposed tariffs?
A:We're seeing stable to slight increases in utilization, but the IV solution issue is a concern. We're also making investments in technologies to identify areas of spend without contracts and helping health systems manage high labor costs.
Q:Can you clarify the current portion of the liability related to the sale of future revenues to OMNIA?
A:The current portion reflects anticipated amounts we will need to pay back to OMNIA during fiscal 2025, based on expected purchasing.
Q:How did the IV bag shortages affect your numbers and guidance?
A:The impact varies by health system, but we do not expect it to have a material impact on our second quarter performance.
Q:Review of Unclear Management Responses
A:Management's response to the question about the sustainability of core utilization and the impacts of proposed tariffs lacked clarity, as it was complex and did not provide specific data or a clear direction.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
COVID
Chain Services
Contigo Health
Health Systems
Healthcare Systems
IV solution
Number
OMNIA
Sciences
Supply Chain
agency
amount
cadence
community
contract penetration
contract renewal
decline
development
distributor
divestiture
engagement
follow
government
group
healthcare system
impact
inventory
investment
liability
lot
outcome
procedure
program
reminder
renewal process
supplier
tariff
timing
world
PINC Transcript
Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript
Positive8-19
The earnings call reveals strong financial performance, with increased guidance for EBITDA and EPS, and a strategic partnership with Epic. The Q&A highlights growth in advisory services and stable supply chain conditions. Despite some vague responses, the company's strategic initiatives and optimistic guidance suggest a positive stock movement. The market cap indicates a moderate reaction, leading to a prediction of a positive stock price movement (2% to 8%) over the next two weeks.
Premier, Inc. (PINC) Q3 2025 Earnings Call Transcript
Unknown5-6
The earnings call presents a mixed picture: strong financial metrics with increased adjusted EPS and EBITDA, but lower net revenue and challenges in Performance Services. The Q&A highlights concerns about rising costs, tariffs, and workforce shortages. Positive factors include a share repurchase program and dividend yield, but these are offset by uncertainties in revenue guidance and macroeconomic pressures. Given the company's market cap and the balanced positive and negative elements, a neutral stock price movement is expected over the next two weeks.
Premier, Inc. (NASDAQ:PINC) Q2 2025 Earnings Call Transcript
Unknown2-5
The earnings call presents a mixed picture: strong shareholder returns via buybacks and dividends, but financials show declining revenue and a net loss due to impairment charges. The Q&A highlights resilience in administrative fees and supply chain strategies but also reveals uncertainties regarding tariffs and consulting services. Given the stable guidance and mixed financial performance, the stock is likely to remain neutral, with potential slight fluctuations due to market sentiment.
Premier, Inc. (PINC) Q1 2025 Earnings Call Transcript
Unknown11-5
The earnings call indicates mixed signals: financial performance declined YoY, but there was a notable gain from a lawsuit settlement. The company announced a significant share repurchase and dividend payout, which are positive. However, management's vague responses on certain issues during the Q&A, coupled with an 8% revenue decline, suggest uncertainty. The market cap indicates a moderate reaction, resulting in a neutral stock price prediction.
PINC Slides
PINC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
